OrbiMed, a global investment management firm focused on the healthcare sector, announced the launch of a $222 million investment fund dedicated to life sciences venture capital opportunities based in Israel. The fund, OrbiMed Israel Partners Limited Partnership, includes an anchor investment provided by the Government of Israel. According to OrbiMed, the fund is led by three Israel-based partners – Dr. Nissim Darvish, Anat Naschitz and Erez Chimovits.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments